维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="Mader RM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro显示文摘	Links-Schonau KK Steger GG Mader RM	2007	Cancer Lett2007，257，1：	1
2	Influence of neoadjurant therapy with epirubicin and docetaxel On the expression of HER2/nell in pafienm witlI breast cancer显示文摘	] Taueher s Rudas M Mader RM et a1	2003	Breast Cancer Res Treat2003，82，3：	1
3	5-Fluorouracil kinetics in the interstitial tumor space:clinical response in breast cancer patients显示文摘	Muller M Mader RM Steiner B	1997	Cancer Res1997，57，13：	1
4	Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER 2/neu in patients with breast cancer显示文摘	Taucher S Rudas M Mader RM	2003	Breast Cancer Res Treat2003，82，3：	1
5	Prognostic markers in breast cancer:the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer显示文摘	Taucher S Rudas M Mader RM		0，，1：	1
6	Angiogenic effect of naive and5fluorouracil resistant colon carcinoma on endothelial cells in vitro显示文摘	Schonau KK Steger GG Mader RM	2007	Cancer Lett2007，257，1：	1
7	Angiogenic effect of naive and 5-fiuorouracil resistant colon carcinoma on endothelial cells in vitro 显示文摘	Schonau KK Steger GG Mader RM	2007	Cancer Lett2007，257，1：	1
8	Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer显示文摘	Taucher S Rudas M Mader RM	2003	Breast Cancer Res Treat2003，82，3：	1
9	Effect of timing and numberof baseline blood pressure determinations on postural blood pressureresponse显示文摘	Mader SL Palmer RM Rubenstein LZ	1989	J Am Geriatr Soc1989，37，5：	1
10	Do we need HER-2/neu testing for all patients with primary breast carcinoma?显示文摘	Taucher S Rudas M Mader RM	2003	Cancer2003，98，12：	1
11	Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer 显示文摘	Taucher S Rudas M Mader RM	2003	Breast Cancer Res Treat2003，82，3：	1
12	Influence of necadjuvanttherapy with epirubiein and doeetaxel on the expression of HER2/neu in patients with breast cancer 显示文摘	Taucher S Rudas M Mader RM	2003	Breast Cancer Res Treat2003，82，3：	1
13	Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer 显示文摘	Taucher S Rudas M Mader RM	2003	Breast Cancer Res Treat2003，82，3：	1
14	Influence ofneoadjurant therapy with epirubicin and docetaxel on the expression of HER2/neu in pafienm witⅡ breast cancer显示文摘	Taueher S Rudas M Mader RM	2003	Breast Cancer Res Treat2003，82，3：	1
15	Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer 显示文摘	Taucher S Rudas M Mader RM	2003	Breast Cancer Res Treat2003，82，3：	1
16	Resistance to 5-fluorouracil显示文摘	Muller M Steger GG	1998	Gen Pharmacil1998，31，5：	1
17	Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer显示文摘	Mader RM Schrolnberger C Rizovski B	2003	British Journal of Cancer2003，88，5：	1
18	Do we need HER-2Pneu testing for All patients with primary breast carcinoma显示文摘	Rudas M Mader RM	2003	Cancer2003，98，12：	1
19	5-fluorouracil kinetics in the interstitical tumor space:clinical response in breast cancer patients显示文摘	Müller M Mader RM Steiner B	1997	Cancer Res1997，57，13：	1
20	Do we need HER- 2/neu testing for all patientswith primary breast carcinoma 显示文摘	Taucher S RudasM Mader RM etal	2003	Cancer2003，98，12：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示